We enhance care, provide support and strive to eliminate Alzheimer's disease through the advancement of research in our state-of-the-art laboratories.

Our Mission


Congratulations! Graduate Students at Appel Institute are Awarded F31 Fellowships!

Graduate students within the Appel Institute, Stephanie Jackvony, Lauren Komer, and Gillian Carling have been awarded F31 predoctoral fellowships from the NIH. Stephanie Jackvony’s project is titled...

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models

Congratulations to the Sharma lab for their recent work on alpha-synuclein pathogenesis recently published in Nature Communications!In collaboration with the Burré lab, also at the Appel Institute,...

A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states

A collaborative effort between the Gan lab at the Appel Institute and the Kampmann lab at UCSF reveals regulators of disease states in a recent publication out now in Nature Neuroscience. The authors...

Appel Alzheimer's Disease Research Institute | Click Here